Sahar Issa | Health Professions | Best Researcher Award

Prof. Dr. Sahar Issa | Health Professions | Best Researcher Award

Faculty of medicine, Alexandria University | Egypt

Dr. Sahar Issa, is a distinguished Professor of Forensic Medicine, Clinical Toxicology, and Medical Ethics at the Faculty of Medicine, University of Alexandria, Egypt. She earned her Ph.D. in Forensic Medicine and Clinical Toxicology from Alexandria University, following an M.Sc. in Forensic Medicine & Clinical Toxicology and a Diploma in Public Health specializing in Vector Control and Pesticide Residues Toxicities, alongside her MBChB in Medicine and Surgery. Over her extensive academic career, Dr. Sahar Issa has combined rigorous teaching with cutting-edge research in forensic medicine, toxicology, and medical ethics, contributing to enhanced clinical and forensic practices. Her research interests include toxicological analysis, forensic pathology, sex determination using skeletal traits, and the assessment of chemical and microbial hazards. She has published several influential works, including her book Forensic Toxicology: Poisoning in the Modern World (IntechOpen, 2019) and Microbial Witness: Unraveling Mysteries with Forensic Microbiomes (IntechOpen, 2023). Her peer-reviewed articles cover a wide range of topics such as fentanyl and ketamine effects on liver biochemistry (Toxicology, 2003), forensic toxicology of suicidal and accidental poisonings (Egyptian Journal of Forensic Sciences, 2016), and postmortem trace element analysis (J Forensic Leg Med, 2022), with many of her studies widely cited for their clinical and forensic relevance. Recognized for her contributions to education, toxicology consultation, and public health, Dr. Sahar Issa exemplifies excellence in research, bridging laboratory insights with practical forensic applications and mentoring the next generation of forensic scientists globally.

Profile: Google Scholar | ORCID | LinkedIn

Featured Publications

Hafez, E. M., Issa, S. Y., Ai-Mazroua, M. K., Ibrahim, K. T., & Rahman, S. M. A. (2016). The neonicotinoid insecticide imidacloprid: A male reproductive system toxicity inducer-human and experimental study.

Hafez, M. E., Issa, Y. S., & Abdel Rahman, M. S. (2015). Parenchymatous toxicity of tramadol: Histopathological and biochemical study. Journal of Alcohol and Drug Dependence, 3(5), 225.

Issa, S. Y., Khanfour, A. A., & Kharoshah, M. (2016). A model for stature estimation and sex prediction using percutaneous ulnar and radial lengths in autopsied adult Egyptians. Egyptian Journal of Forensic Sciences, 6(2), 84–89.

Ibrahim, S. Y. (2016). Determination of heavy metals and other toxic ingredients in henna (Lawsonia inermis). Journal of Environmental & Analytical Toxicology, 6(3), 9.

Cebolla, S. G., [et al.]. (2018). Fully automated forensic routine dried blood spot screening for workplace testing. Journal of Analytical Toxicology, 43(2), 1–11.

Issa, S. Y., Hafez, E. M., El-Banna, A. S., Abdel Rahman, S. M., AlMazroua, M. K., … [et al.]. (2018). Baclofen systemic toxicity: Experimental histopathological and biochemical study. Human & Experimental Toxicology, 37(4), 431–441.

Zagloul, N. M., Farghaly, R. M., ELKhatib, H., Issa, S. Y., & El-Zoghby, S. M. (2022). Technology facilitated sexual violence: A comparative study between working and non-working females in Egypt before and during the COVID-19 pandemic. Egyptian Journal of Forensic Sciences, 12(1), 21.

Alalawi, S., Issa, S. T., Takshe, A. A., & ElBarazi, I. (2022). A review of the environmental implications of the COVID-19 pandemic in the United Arab Emirates. Environmental Challenges, 8, 100561.

Eddine, N. N., Noisel, N., Dieme, D., Asmar, M. K., Issa, S. T., & Bouchard, M. (2022). Multi-matrix biomonitoring approach to assess exposure to metals and trace elements in the Lebanese population and associations with drinking water consumption. Environmental Research, 214, 113982.

Long Chang | Medicine and Health Sciences | Best Researcher Award

Dr. Long Chang | Medicine and Health Sciences | Best Researcher Award

Peking Union Medical College Hospital | China

Dr. Long Chang is an accomplished physician and clinical researcher whose career demonstrates excellence in patient care and significant contributions to hematology. He currently serves as an Attending Physician at the Department of Hematology, Peking Union Medical College Hospital, Beijing, China, building upon his medical training at Peking Union Medical College, Tsinghua University. His research focuses on rare hematologic disorders, particularly myeloproliferative neoplasms and histiocytic diseases, with emphasis on improving diagnostic precision, expanding therapeutic strategies, and enhancing patient outcomes. According to Scopus (Author ID: 57225110413), Dr. Long Chang has authored 39 publications, which have collectively received 165 citations across 152 documents, reflecting the impact of his work, and holds an h-index of 6. He has published influential studies in leading journals including Leukemia, EClinicalMedicine, Oncologist, and Orphanet Journal of Rare Diseases. His work has advanced treatment options for Rosai-Dorfman disease and Langerhans cell histiocytosis while also providing novel insights into gamma heavy chain disease. Notably, his clinical trials have introduced promising approaches such as low-dose cytarabine and novel immunomodulatory therapies, offering alternatives for conditions with limited treatments. Beyond publications, Dr. Long Chang demonstrates commitment to translational medicine by bridging molecular research with patient-centered care. Recognized by peers for his rigor, innovation, and leadership, he has progressed from Resident and Chief Resident to Attending Physician, reflecting both clinical expertise and academic excellence. With impactful contributions influencing practice worldwide, Dr. Long Chang exemplifies the qualities of a dedicated physician-scientist whose work continues to advance the frontiers of hematology.

Profile: Scopus

Featured Publications

  • Chang, L., Zhou, D. B., & Cao, X. X. (2023). Gamma heavy chain disease: A retrospective analysis of 6 cases. Orphanet Journal of Rare Diseases, 18(1), 77.

  • Chang, L., Qiao, B., Cai, H., et al. (2023). Clinical phenotypes, molecular analysis, and outcomes of patients with Rosai-Dorfman disease. Leukemia, 37(11), 2297–2300.

  • Chang, L., Lang, M., Lin, H., et al. (2024). Phase 2 study using low dose cytarabine for adult patients with newly diagnosed Langerhans cell histiocytosis. Leukemia, 38(4), 803–809.

  • Chang, L., Lang, M., Liu, T., et al. (2024). Lenalidomide and dexamethasone for Rosai-Dorfman disease: A single arm, single center, prospective phase 2 study. EClinicalMedicine, 73, 102685.

  • Chang, L., Cai, H. C., Lang, M., et al. (2024). Liver involvement with Langerhans cell histiocytosis in adults. The Oncologist. Advance online publication.

Liliang Li | Medicine and Health Sciences | Excellence in Innovation Award

Prof. Liliang Li | Medicine and Health Sciences | Excellence in Innovation Award

Fudan University | China

Prof. Liliang Li is a leading Associate Professor at Fudan University Shanghai Medical College, recognized for her pioneering research in forensic medicine, cardiovascular biology, and translational pharmacology. She has made significant contributions to understanding the molecular mechanisms underlying antipsychotic-induced cardiotoxicity, diabetic heart injuries, and sudden unexplained death in psychiatric patients. Combining innovative molecular approaches with clinical applications, Dr. Li’s research has consistently bridged basic science and translational medicine, influencing both diagnostic strategies and therapeutic development.

Professional Profile

Scopus

ORCID

Education

Prof. Liliang Li received her medical degree in Forensic Medicine followed by a doctoral degree in Forensic Science from Fudan University Shanghai Medical College. She enhanced her academic foundation and international exposure through postdoctoral training and a visiting scholar program at the University of Maryland School of Medicine, enabling her to integrate global perspectives into her research.

Experience

Prof. Liliang Li has built an impressive academic and research career, progressing from postdoctoral fellow to Associate Research Fellow, and ultimately assuming her current role as Associate Professor. She has played key roles in mentoring young researchers, organizing graduate research conferences, and serving as a talent specialist. She actively participates in professional committees, including leadership positions within the Shanghai Society of Forensic Medicine, the Shanghai Association of Forensic Expertise, and cardiovascular research societies, demonstrating both scientific excellence and professional commitment.

Research Interests

Her research focuses on the mechanisms of antipsychotic-induced cardiotoxicity, cannabinoid receptor-mediated myocardial signaling, and cell death pathways including necroptosis and pyroptosis. Prof. Liliang Li is particularly interested in the identification of biomarkers for sudden cardiac death and diabetic cardiac injuries. Her work integrates multi-omics approaches, including proteomics, transcriptomics, and molecular biology, to unravel complex cardiovascular and forensic phenomena, with an emphasis on developing translational strategies for clinical and forensic applications.

Awards

Prof. Liliang Li’s innovative work has been widely recognized with numerous prestigious awards, including Young Investigator accolades, national and regional medical science awards, and multiple best paper honors at leading cardiology conferences. She has been nominated for international awards in toxicology, chaired sessions at major scientific meetings, and serves as a reviewer for high-impact journals in cardiovascular medicine, translational research, and molecular biology. These accolades reflect her influence on both national and international scientific communities.

Publications

  • Title: Coenzyme Q deficiency may predispose to sudden unexplained death via an increased risk of cardiac arrhythmia
    Journal: International Journal of Legal Medicine
    Published on: 2024

  • Title: RNF149 Destabilizes IFNGR1 in Macrophages to Favor Postinfarction Cardiac Repair
    Journal: Circulation Research
    Published on: 2024

  • Title: Cardiotoxic effects of common and emerging drugs: role of cannabinoid receptors
    Journal: Clinical Science
    Published on: 2024

  • Title: Post-mortem genetic analysis of sudden unexplained death in a young cohort: a whole-exome sequencing study
    Journal: International Journal of Legal Medicine
    Published on: 2023

  • Title: Nasal mucosa is much more susceptible than oral mucosa to infection of SARS‐CoV‐2 Omicron subvariants: Wearing nasal masks where facial masks cannot be used
    Journal: Journal of Medical Virology
    Published on: 2023

  • Title: Sudden unexplained death in schizophrenia patients: An autopsy-based comparative study from China
    Journal: Asian Journal of Psychiatry
    Published on: 2023

  • Title: Cannabinoid Receptor 2-Centric Molecular Feedback Loop Drives Necroptosis in Diabetic Heart Injuries
    Journal: Circulation
    Published on: 2023

Conclusion

Prof. Liliang Li is an exceptional scientist whose work exemplifies innovation, rigor, and translational impact. Her integration of forensic science, molecular cardiology, and translational medicine has led to new insights into drug-induced cardiotoxicity and sudden cardiac death. With a remarkable combination of research excellence, leadership, and mentorship, Dr. Li continues to shape the future of cardiovascular and forensic research, making her a highly deserving candidate for the Excellence in Innovation Award.

Xuanlong Chen | Medicine and Health Sciences | Best Researcher Award

Mr. Xuanlong Chen | Medicine and Health Sciences | Best Researcher Award

Fudan University | China

Mr. Xuanlong Chen is a promising researcher in forensic pathology with a strong academic foundation and a growing record of impactful contributions. Known for his dedication and meticulous approach to scientific inquiry, he has already demonstrated significant potential in advancing forensic research. His work combines cutting-edge molecular techniques with practical forensic applications, reflecting both innovation and a commitment to improving diagnostic accuracy in complex medico-legal cases. He has been recognized for academic excellence through multiple scholarships and awards, positioning him as a notable candidate for the Best Researcher Award.

Professional Profile

Scopus

Education

Mr. Xuanlong Chen completed his Bachelor’s degree at Nanjing Medical University, China, where he developed a strong background in medical sciences and research methodology. Currently, he is pursuing a Master’s degree at Fudan University, focusing on forensic pathology and molecular forensic research. During his academic journey, he has received several university-level scholarships, been honored as an Outstanding Student, and awarded the prestigious National Scholarship, reflecting his consistent dedication to academic and research excellence.

Experience

As a graduate researcher, Mr. Xuanlong Chen has undertaken advanced projects that combine single-nucleus RNA sequencing and machine learning to identify potential biomarkers in sudden unexplained deaths among psychiatric patients. He has contributed to developing predictive identification models for sudden death cases, addressing critical challenges in forensic pathology. In addition, he has conducted comprehensive reviews on rare toxicological phenomena, such as bongkrekic acid poisoning, demonstrating both breadth and depth in his research. Although early in his career, his proactive approach and innovative methods reflect significant research maturity.

Research Interests

His primary research focus is forensic pathology, particularly investigating molecular and cellular mechanisms underlying sudden unexplained deaths. He also explores toxicological studies and the identification of biomarkers for psychiatric-related mortalities. By integrating molecular biology, bioinformatics, and forensic analysis, he aims to develop practical diagnostic tools and predictive models that enhance forensic accuracy and provide valuable insights for medico-legal investigations.

Awards

Throughout his academic career, Mr. Xuanlong Chen has been recognized for excellence through multiple scholarships and university awards, including the highly competitive National Scholarship and several “Outstanding Student” honors. These accolades reflect his consistent academic performance, innovative research approach, and commitment to advancing knowledge in forensic pathology.

Publications

Mr. Xuanlong Chen has published several peer-reviewed articles in internationally recognized journals, reflecting his research contribution and growing scientific impact. His work includes studies on single-nucleus RNA sequencing and machine learning in forensic pathology and comprehensive reviews of toxicological phenomena. Selected publications include:

  • Title: Single-nucleus RNA sequencing and machine learning identify CACNA1A as a myocyte-specific biomarker for sudden unexplained death in schizophrenia
    Journal: Forensic Science International

  • Title: A comprehensive review on bongkrekic acid poisoning
    Journal: Journal of Forensic Medicine

Conclusion

Mr. Xuanlong Chen is a dedicated and innovative researcher whose academic accomplishments, publications, and contributions to forensic pathology exemplify excellence. His work in biomarker identification and toxicological studies demonstrates both scientific creativity and practical relevance, making him a highly deserving candidate for the Best Researcher Award. His dedication, forward-thinking approach, and growing influence in forensic research underscore his potential to make significant contributions to the scientific community.

Fatemeh Shirani | Medicine and Health Sciences | Women Researcher Award

Dr. Fatemeh Shirani | Medicine and Health Sciences | Women Researcher Award

Endocrine and Metabolism Research Center | Iran

Dr. Fatemeh Shirani is a distinguished scholar in the field of Nutritional Sciences, renowned for her groundbreaking contributions to clinical nutrition, dietary epidemiology, and metabolic health. She has consistently advanced the understanding of how diet and nutrition influence chronic disease prevention and treatment, with a strong emphasis on obesity, diabetes, and cardiovascular disease. Through her innovative research and global collaborations, she has established herself as a thought leader whose work bridges scientific evidence with practical dietary strategies for public health. Currently serving at the Endocrine and Metabolism Research Center of Isfahan University of Medical Sciences, she has become a role model for women in science through her dedication, mentorship, and international engagement.

Professional Profile

Google Scholar

ORCID

Education

Dr. Fatemeh Shirani completed her academic journey with distinction in Nutritional Sciences, earning her foundational and advanced degrees from leading Iranian institutions. She further enriched her expertise through doctoral-level research at Ahvaz Jundishapur University of Medical Sciences, where she focused on the intricate links between nutrition and chronic diseases. Her academic training was complemented by international research at Victoria University in Melbourne, Australia, where she deepened her skills in nutritional biomedicine and clinical research methodologies. This comprehensive educational background provided her with a strong platform to integrate theoretical knowledge with practical application in clinical and population-based nutrition research.

Experience

Dr. Fatemeh Shirani has accumulated extensive experience across research, teaching, and scientific service. She has contributed to large-scale community-based projects, such as national nutrition surveys and heart health programs, aimed at improving public health outcomes through evidence-based interventions. As a dedicated educator, she has taught undergraduate and graduate students, instilling in them the principles of basic nutrition, clinical dietetics, and community health. Her expertise extends to laboratory techniques such as PCR and cell culture, which she has applied to translational nutrition studies. Beyond academia, she has actively participated as a reviewer for prestigious international journals, shaping the quality of published science in her field. Her professional journey reflects a balance of teaching, research, community service, and scientific leadership.

Research Interests

Dr. Fatemeh Shirani’s research interests lie at the intersection of nutrition, epidemiology, and chronic disease management. She is deeply invested in exploring obesity and weight-loss strategies, nutritional interventions for diabetes and metabolic disorders, and the role of diet in preventing cardiovascular disease. Her work also investigates the emerging field of “infectobesity,” examining the connections between viral infections and obesity. By employing systematic reviews, meta-analyses, and clinical trials, she provides high-quality evidence that informs dietary recommendations and policy guidelines. Her studies not only address the biological mechanisms of nutrition-related diseases but also emphasize the translation of findings into practical interventions for populations at risk.

Awards

Dr. Fatemeh Shirani has been widely recognized for her contributions to nutritional sciences, particularly her ability to merge clinical expertise with public health perspectives. Her nomination for the Women Researcher Award reflects her outstanding achievements in advancing women’s representation in scientific leadership and her sustained impact on global nutrition research. She has consistently demonstrated excellence through her publications, conference presentations, and active participation in national and international nutrition societies. This recognition highlights not only her scientific accomplishments but also her commitment to mentoring young researchers and fostering collaborative networks across borders.

Publication

Dr. Fatemeh Shirani has produced a rich body of work that has been widely cited in international literature. Selected publications include:

Title: Effects of Dietary Approaches to Stop Hypertension (DASH)-style diet on fatal or nonfatal cardiovascular diseases incidence: a systematic review and meta-analysis
Journal: Nutrition
Published on: 2013
Citation: 482

Title: The effect of dietary approaches to stop hypertension (DASH) diet on weight and body composition in adults: a systematic review and meta‐analysis of randomized controlled trials
Journal: Obesity Reviews
Published on: 2016
Citation: 308

Title: Effects of Dietary Approaches to Stop Hypertension (DASH) diet on some risk for developing type 2 diabetes: a systematic review and meta-analysis on controlled clinical trials
Journal: Nutrition
Published on: 2013
Citation: 288

Title: The role of magnesium in sleep health: a systematic review of available literature
Journal: Biological Trace Element Research
Published on: 2023
Citation: 104

Title: Is phase angle a valuable prognostic tool in cancer patients’ survival? A systematic review and meta-analysis of available literature
Journal: Clinical Nutrition
Published on: 2021
Citation: 98

Title: Vinegar consumption can attenuate postprandial glucose and insulin responses; a systematic review and meta-analysis of clinical trials
Journal: Diabetes Research and Clinical Practice
Published on: 2017
Citation: 95

Title: Effects of concentrated pomegranate juice on subclinical inflammation and cardiometabolic risk factors for type 2 diabetes: A quasi-experimental study
Journal: International Journal of Endocrinology and Metabolism
Published on: 2016
Citation: 55

Conclusion

In conclusion, Dr. Fatemeh Shirani stands as a leading figure in nutritional sciences whose contributions have advanced both research and practice in the prevention and management of chronic diseases. Her ability to translate complex scientific findings into practical dietary strategies has had a lasting impact on public health. With her strong publication record, global collaborations, and dedication to mentorship, she exemplifies the qualities of an outstanding woman researcher. Her nomination for the Women Researcher Award reflects not only her academic excellence but also her leadership, vision, and commitment to improving health outcomes through nutrition science.

Begum Ertan | Medicine and Health Sciences | Young Researcher Award

Dr. Begum Ertan | Medicine and Health Sciences | Young Researcher Award

Sandikli State Hospital | Turkey

Dr. Begum Ertan is an accomplished medical doctor and specialist in Gynecology and Obstetrics, serving at Afyonkarahisar Sandikli State Hospital. She is recognized for her dedication to advancing women’s reproductive health, blending clinical expertise with a strong commitment to academic research. Her work spans adenomyosis diagnosis, infertility treatment, IVF success prediction, and gynecologic oncology. Actively engaged in professional societies, she is a core group member of the Turkish Endometriosis and Adenomyosis Society. Dr. Ertan combines patient-centered care with cutting-edge scientific approaches, striving to improve diagnostic accuracy, treatment outcomes, and overall quality of life for women.

Professional Profile

Scopus

Education

Dr. Ertan completed her medical degree at Celal Bayar University, Faculty of Medicine, where she laid a strong foundation in clinical sciences and patient care. She then specialized in Obstetrics and Gynecology at Dokuz Eylül University, Faculty of Medicine, developing advanced skills in reproductive medicine, maternal-fetal health, and minimally invasive surgical techniques. Her education was enriched by exposure to diverse clinical cases and participation in academic projects, fostering her dual role as a skilled clinician and committed researcher.

Experience

With extensive experience as a Gynecology and Obstetrics Specialist, Dr. Ertan has managed complex cases involving high-risk pregnancies, reproductive endocrinology, and gynecologic surgery. She has contributed to multidisciplinary medical teams, enhancing patient outcomes through evidence-based approaches. Her professional activities include presenting original research at leading national and international conferences, authoring peer-reviewed publications, and writing academic book chapters on endometriosis, infertility, and hormonal therapies. In addition to her hospital duties, she actively participates in community health initiatives, delivering educational seminars on women’s health and hygiene.

Research Interests

Dr. Ertan’s research is driven by a commitment to improving women’s reproductive health through innovative diagnostic and therapeutic methods. She is particularly interested in adenomyosis detection using advanced imaging modalities, identifying predictive factors for IVF success, evaluating the impact of early pregnancy findings on pregnancy outcomes, and exploring rare gynecologic pathologies. Her studies also address the role of hysteroscopic evaluation in abnormal uterine bleeding and the relationship between ovarian conditions and fertility potential. By integrating clinical insight with research innovation, she aims to bridge the gap between academic findings and real-world patient care.

Awards

Dr. Ertan’s professional trajectory reflects the qualities sought in the Young Researcher Award  innovation, dedication, and measurable contributions to the field. Her growing portfolio of scientific publications, her active participation in professional societies, and her involvement in public health education underscore her status as a promising and impactful early-career researcher in obstetrics and gynecology.

Publications

  • Title: Prediction of adenomyosis according to revised definitions of morphological uterus sonographic assessment features
    Journal: Frontiers in Medicine
    Published on: August 2024

  • Title: Comparison of Patients with Adenomyosis Detected in Hysterectomy Material and Patients with Other Benign Pathologies: Retrospective Study
    Journal: Turkish Journal of Reproductive Medicine and Surgery
    Published on: 2024

  • Title: Impact of ovarian cysts observed on the initial day of ovulation induction on the success rates in IVF cycles
    Journal: Reproductive Bio Medicine Online
    Published on: November 2023

  • Title: Correlation of adenomyosis risk factors with pathologic diagnosis
    Journal: Reproductive Bio Medicine Online
    Published on: November 2023

  • Title: Pregnancy Loss Prediction Based on Early First Trimester Ultrasound
    Journal: Reproductive Bio Medicine Online
    Published on: November 2023

  • Title: Ovarian hilus cell hyperplasia and sertoli-leydig cell tumor in a patient with postmenopausal virilization: a rare case report
    Journal: Aegean Journal of Obstetrics and Gynecology
    Published on: December 2021

Conclusion

Dr. Begum Ertan embodies the profile of an emerging leader in reproductive medicine. Her clinical expertise, research productivity, and academic contributions have already made a significant impact on the field. Through her continued work in advanced gynecologic diagnostics, fertility treatment, and women’s health advocacy, she demonstrates exceptional promise as a young researcher. Her commitment to bridging scientific innovation with practical healthcare solutions makes her a strong and deserving candidate for the Young Researcher Award.

Ji Li | Medicine and Health Sciences | Best Scholar Award

Prof. Ji Li | Medicine and Health Sciences | Best Scholar Award

Central South University | China

Professor Ji Li, PhD, is a distinguished scholar in dermatological sciences, currently serving in the Department of Dermatology at Xiangya Hospital, Central South University, China. Renowned for groundbreaking research in inflammatory dermatosis and skin aging, Professor Ji has significantly advanced clinical and molecular dermatology through over a decade of academic contributions.

Author Profile👤

Scopus

Strengths for the Awards✨

Professor Ji Li, PhD, has firmly established herself as a leading figure in dermatological research, particularly in the areas of inflammatory dermatosis and skin aging. Her academic contributions are highly impactful, with over 100 SCI-indexed publications in prestigious international journals, such as BMJ, Science Advances, Developmental Cell, EMBO Journal, JAAD, JAMA Dermatology, and Journal of Investigative Dermatology. This extensive publication record underscores her sustained productivity and global recognition.

In addition to scholarly output, her ability to attract six projects funded by the National Natural Science Foundation of China (NSFC) demonstrates her competence in leading significant, peer-reviewed scientific research with national and institutional importance. Her dual roles as first and corresponding author reflect intellectual leadership and mentorship capability, making her a strong candidate for the Best Scholar Award.

🎓 Education

Professor Ji Li earned a Ph.D. in Dermatology and has since cultivated a strong academic foundation that supports both clinical excellence and scientific innovation. Their academic journey is rooted in top-tier institutions, combining rigorous research training with a focus on translational skin biology.

🧪 Experience

With a long-standing tenure at Xiangya Hospital, Professor Ji Li has blended clinical dermatology practice with laboratory-based investigation, leading several research groups and mentoring young scientists. With active involvement in national and international dermatological communities, Ji Li is recognized as a clinical-scientific leader in the field.

🔬 Research Interest On Medicine and Health Sciences

Professor Ji’s core research areas include:

  • Inflammatory dermatoses, exploring molecular mechanisms and treatment strategies

  • Skin aging, investigating cellular aging pathways and potential rejuvenation therapies
    These interests are supported by a rich body of work that bridges clinical needs and molecular science.

🏆 Award

Professor Ji Li has been honored with several prestigious recognitions, including grants from the National Natural Science Foundation of China (with 6 funded projects), underlining the scientific community’s acknowledgment of Ji’s excellence and innovation. The consistent impact of Ji’s work positions them as a leading nominee for the Best Scholar Award.

📚 Publications

Professor Ji Li has authored over 100 SCI-indexed papers as first or corresponding author, published in top-tier international journals. Notable recent publications include:

💡 Conclusion

Professor Ji Li exemplifies the values of the Best Scholar Award through a rare combination of clinical expertise, scientific vision, and impactful scholarship. With extensive contributions to inflammatory skin diseases and aging, an outstanding publication record, and robust grant support, Ji stands out as a trailblazer in dermatology research. Their leadership continues to inspire innovation, mentorship, and global collaboration.

Niloofar Choobin | Health Professions | Best Researcher Award

Dr. Niloofar Choobin | Health Professions | Best Researcher Award

Hormozgan University of Medical Sciences | Iran

Dr. Niloofar Choobin is an accomplished Iranian researcher and healthcare informatics specialist, renowned for her pioneering work in artificial intelligence applications in healthcare. With a Master’s degree in Health Information Technology (expected 2025) and a strong academic foundation, she has emerged as a dynamic contributor to clinical decision support systems, digital health innovations, and AI-driven diagnostics. Her research spans key domains including cardiovascular health, oncology, and telemedicine. Recognized through multiple national awards and academic honors, she also serves as a mentor, workshop organizer, and reviewer for various research initiatives in Iran.

Author Profile👤

Google Scholar

ORCID

Scopus

Strengths for the Awards✨

Niloofar Choobin stands out as a forward-thinking and technically adept researcher in the field of Health Information Technology, with a unique focus on AI-powered clinical diagnostics and digital health innovation. Her academic training—spanning a BSc and an ongoing MSc at Hormozgan University—has been translated into impactful research projects such as machine learning models for coronary artery disease and hypertension prediction using cohort data. She has presented her work at multiple national and international congresses and led workshops on systematic reviews and AI-driven healthcare tools, showcasing strong communication and mentoring abilities.

Her award history—including honors like the Top Researcher award, Innovation Finalist at the National Olympiad, and a 2nd place at the Health IT Innovation Festival—reinforces her standing as a leader among young Iranian researchers. Her cross-disciplinary expertise, including NLP, wearable tech, and IoT in medicine, bridges clinical and computational sciences. These achievements, along with her active involvement in peer review and academic organizing roles, reflect the hallmark of a researcher poised for global recognition.

🎓 Education

Niloofar completed her Bachelor of Science in Health Information Technology from Hormozgan University of Medical Sciences, Iran, in 2015. Currently, she is pursuing her Master of Science in Health Information Technology from the same institution (2023–2025), where her thesis focuses on the development and validation of machine learning models for early detection of coronary artery disease. Her academic path reflects a strong blend of theoretical learning and real-world clinical research applications.

💼 Experience

With a decade of progressive professional experience, Niloofar has held pivotal roles across Iran’s healthcare system. She currently serves as the Educational Affairs and Medical Student Coordinator at the Children’s Hospital in Bandar Abbas, where she facilitates medical education and research training. She has previously worked as a Medical Records Analyst at Chamran Trauma Hospital and as a Clinical Admissions Officer at Kosar Heart Hospital, demonstrating her extensive background in health data management and clinical informatics operations.

🧠 Research Interests On Health Professions

Niloofar’s research interests lie at the intersection of artificial intelligence and clinical medicine. She specializes in:

  • AI-powered clinical decision support

  • Machine learning models for cardiovascular and oncology diagnostics

  • Digital health innovations including IoT and smart monitoring

  • Natural language processing in medical documentation and text data

Her interdisciplinary approach bridges informatics, machine learning, and real-time patient care.

🏅 Awards

Niloofar’s innovative spirit has earned her numerous accolades. She was honored as the Top Researcher by the Hormozgan Student Research Committee (2014–2015) 🥇. In 2023, she was a finalist in the National Olympiad in Entrepreneurship and AI, and secured 2nd place at the National Health IT Innovation Festival in Mashhad (2022). She also won the Provincial Innovation Award in 2015, cementing her status as a promising researcher and innovator in digital health and AI.

📚 Publications

Niloofar has contributed to both academic literature and national congresses with a strong focus on AI applications in healthcare. Selected publications include:

  • Tracking Health: Wearable Technology in Cancer Care – A systematic review analyzing wearable solutions in oncology monitoring. (Published 2023)

  • Smart Post-Chemotherapy Care: IoT and AI-based Monitoring System for Breast Cancer Patients (Submitted, 2024)

  • Telemedicine in Hypertension Management During COVID-19 – A comprehensive review of remote care strategies during the pandemic. (Published 2022)

She has delivered numerous national/international presentations on topics such as:

  • VR in surgical simulations

  • OCT image analysis for cardiovascular diseases

  • Machine learning in PCO and osteosarcoma

  • Applications of ChatGPT in modern medicine

🧾 Conclusion

🔍 With a rare blend of technical depth, research acumen, and healthcare domain experience, Niloofar Choobin is a standout candidate for any prestigious research award in health informatics or AI in medicine. Her continued efforts to integrate machine learning into clinical workflows and her passion for digital transformation of healthcare highlight her future potential as a global thought leader in this field. From winning national competitions to mentoring future researchers, she embodies the qualities of innovation, dedication, and academic excellence.

Tashi Negi | Health Professions | Best Researcher Award

Dr. Tashi Negi | Health Professions | Best Researcher Award

Dr. Tashi Negi is a dedicated medical professional specializing in Otorhinolaryngology with a commendable academic and clinical trajectory. His journey began at AIIMS, New Delhi, where he served as a Junior Resident, and is currently continuing at AIIMS, Bathinda as a Senior Resident. With a commitment to advancing ENT practice, especially in resource-limited settings, Dr. Negi has been an advocate for incorporating modern innovations like telemedicine into traditional clinical care. His academic acumen and hands-on expertise have positioned him as a promising contributor to the field of ENT in India.

Professional profile👤

ORCID

Scopus

Strengths for the Awards✨

  • Clinical Relevance and Timely Research:
    Dr. Negi’s research focuses on highly pertinent and emergent topics in Otorhinolaryngology, such as mucormycosis with pulmonary involvement and giant parathyroid adenomas—both of which have substantial clinical implications. The recent case series on mucormycosis aligns with public health concerns during and post the COVID-19 pandemic.

  • Publication in Reputed Journals:
    He has contributed to peer-reviewed publications in the Indian Journal of Otolaryngology and Head & Neck Surgery, indicating a commitment to evidence-based medicine and academic visibility.

  • Diverse Clinical Experience:
    Having served as a Junior Resident at AIIMS Delhi, followed by his role as a Senior Resident at AIIMS Bathinda, Dr. Negi has trained at two premier institutions, enhancing his exposure to a broad range of clinical and research cases.

  • Focus on Technology Integration:
    One of his studies addresses telemedicine in ENT practice in developing nations, which reflects an understanding of healthcare accessibility challenges and the use of digital health solutions.

🎓 Education

Dr. Tashi Negi received his foundational medical education and specialized training in Otorhinolaryngology at the prestigious All India Institute of Medical Sciences (AIIMS), New Delhi, one of India’s premier medical institutions. His rigorous academic curriculum and clinical exposure at AIIMS laid a strong foundation for his ongoing professional achievements.

💼 Experience

Dr. Negi’s professional experience spans two renowned AIIMS institutions. From January 2019 to January 2022, he served as a Junior Resident in Otorhinolaryngology at AIIMS, New Delhi, gaining valuable hands-on experience in a tertiary care setup. Since December 2022, he has been a Senior Resident at AIIMS, Bathinda, where he continues to refine his clinical skills, engage in academic research, and mentor junior colleagues in ENT surgery and patient care.

🔬 Research Interests On Health Professions

Dr. Negi’s research interests lie in the intersection of clinical ENT practice and emerging challenges in public health. His focus areas include telemedicine applications in ENT, rare presentations of endocrine-related ENT disorders, and fungal infections like mucormycosis, particularly in the context of post-COVID complications. His case-based approach and commitment to addressing clinical gaps make his work relevant and timely.

🏆 Awards

While formal awards are not explicitly listed, Dr. Tashi Negi’s impactful publications and consistent involvement with top-tier medical institutions like AIIMS testify to his academic and professional excellence. His role in documenting rare cases and emerging trends reflects his ongoing contribution to the scientific community and his potential for future recognition.

📚 Publications

  1. “Recent Trend of Surge in Pulmonary Involvement in Sinonasal Mucormycosis: A Case Series” (2025), published in Indian Journal of Otolaryngology and Head & Neck Surgery – This study addresses the growing complexity of mucormycosis and its pulmonary involvement post-pandemic.
    👉 Read here | Cited by: 4 articles

  2. “Giant Parathyroid Adenoma Causing Dyspnea: A Rare Clinical Presentation” (2025), featured in Indian Journal of Otolaryngology and Head & Neck Surgery – This paper highlights a unique endocrine manifestation with significant ENT relevance.
    👉 Read here | Cited by: 6 articles

  3. “In Reference to Telemedicine in Otorhinolaryngology Practice in Developing Nations” – While specific journal and citation data are not available, this work contributes to discussions on the integration of digital health in ENT practice.

📝 Conclusion

In summary, Dr. Tashi Negi exemplifies the blend of academic dedication, clinical expertise, and research innovation. From AIIMS New Delhi to Bathinda, his contributions to ENT practice, especially through case documentation and telemedicine advocacy, are commendable. With a growing body of peer-reviewed work and a deep understanding of patient-centered care, Dr. Negi is a valuable asset to the medical community and a deserving nominee for this award.

Haiyan Li | Health Sciences | Best Researcher Award

Prof. Dr. Haiyan Li | Health Sciences | Best Researcher Award

Department of Breast Surgery, the Sixth Affiliated Hospital of Sun Yat-sen University | China

Dr. Haiyan Li is a renowned Chief Physician at the Department of Breast Surgery, the Sixth Affiliated Hospital of Sun Yat-sen University. With a forward-thinking approach to breast oncology, she integrates surgical innovation and aesthetics, pioneering robotic-assisted reconstruction and minimally invasive techniques. As Chair of multiple breast surgery associations in Guangdong, she plays a pivotal role in training hundreds of surgeons across China, influencing clinical practice and elevating patient care standards. Her clinical contributions, academic publications, and leadership have established her as a national leader in aesthetic breast oncology.

Professional profile👤

ORCID

Scopus

Strengths for the Awards✨

  1. Clinical and Academic Leadership: Dr. Li holds several prestigious leadership roles in surgical and medical societies related to breast oncology and reconstruction, indicating her influence in the field.

  2. Innovative Surgical Techniques: She has introduced novel approaches such as “Inverse Development Surgery” and “Defensive Surgical Strategy”, showing her commitment to innovation in patient-centered breast cancer care.

  3. Educational Contributions: As Chair of a key surgical committee, she has trained hundreds of surgeons across China, disseminating advanced minimally invasive techniques.

  4. Research Output:

    • 27 SCI/Scopus-indexed publications

    • A published book (ISBN: 978-7-5659-2929-8) with video demonstrations

    • 152 citations, reflecting moderate impact in her specialized field

    • Funded by the National Natural Science Foundation of China, a prestigious source

    • Robust focus on robotic-assisted surgery and aesthetic outcomes for breast cancer patients, a growing and highly relevant area

  5. Holistic Approach: Her focus on the aesthetic quality of life for breast cancer survivors integrates medical efficacy with psychological well-being, showing depth in translational research.

🎓 Education

Dr. Haiyan Li has built her medical and surgical career through rigorous academic and professional training. She completed her formal medical education and has continuously expanded her expertise in breast oncology and reconstructive surgery through national and international training programs. Her education laid a strong foundation for her specialization in robotic-assisted breast surgeries and innovative oncological approaches.

🩺 Experience

With extensive experience as a Chief Physician, Dr. Li has been instrumental in transforming breast cancer surgery in China. As the Chairperson of multiple professional committees under the Guangdong Medical Education Association and Guangdong Health Management Society, she has organized and led numerous national training workshops. Her signature innovations include the “Inverse Development Surgery” and “Defensive Surgical Strategy”, which are now recognized frameworks for aesthetic-preserving breast cancer operations.

🔬 Research Interests On Health Sciences

Dr. Li’s research is centered around minimally invasive surgery, robotic-assisted breast reconstruction, and aesthetic treatment in breast oncology. Recognizing the emotional and psychological impact of breast loss, her work emphasizes preserving the aesthetic and psychological well-being of patients. She has established a novel model of aesthetic oncology surgery, integrating functionality, oncologic safety, and beauty.

🏆 Awards

Dr. Haiyan Li has earned national recognition for her contributions to breast cancer aesthetics and surgical innovation. She is currently nominated for the Best Researcher Award for her groundbreaking advancements in robotic-assisted surgery and the aesthetic treatment of breast tumors. Her leadership in clinical training and innovation has significantly impacted breast oncology in China.

📚 Publications

Dr. Haiyan Li has authored over 27 peer-reviewed publications, focusing on breast cancer surgery, robotic techniques, and reconstruction. A selection of her key publications is below:

  1. Robotic-assisted nipple-sparing mastectomy with immediate breast reconstruction: initial experiences – Asian Journal of Surgery, 2019
    – Cited by: 35 articles

  2. Aesthetic considerations in oncological breast surgery: A Chinese perspective – The Breast, 2020
    – Cited by: 28 articles

  3. Minimally invasive axillary surgery in breast cancer treatment – Medicine (Baltimore), 2021
    – Cited by: 17 articles

  4. Defensive surgical strategies in breast oncology – Annals of Surgical Oncology, 2020
    – Cited by: 21 articles

  5. Integrating aesthetic outcomes in breast cancer care – Journal of the American College of Surgeons, 2018
    – Cited by: 29 articles

Total Citation Index: 152 📈
Her book 《Aesthetic Surgery of Breast Oncology》 (ISBN: 978-7-5659-2929-8) includes video tutorials and is widely used in medical training programs.

🔚 Conclusion

Dr. Haiyan Li has redefined breast cancer surgery by merging oncologic excellence with aesthetic preservation. Through her pioneering work in robotic-assisted surgeries, groundbreaking surgical strategies, and widespread training programs, she has significantly enhanced patient care and surgical education. Her work embodies innovation, empathy, and excellence, making her a deserving candidate for the Best Researcher Award.